Lawyer Wins Against Insurance Company for Cancer Treatment
Blue Cross and Blue Shield of Louisiana would not pay for the proton therapy to treat Robert Salim’s head and neck cancer, saying it was not medically necessary. But Salim, an attorney, and his doctor believed this form of radiation would cause few side effects that less costly radiation. They appealed, and lost. After several more appeals, Salim paid out of pocket to have the proton therapy at MD Anderson Cancer. After he recovered, he sued the insurance company. Four year later, Salim won his lawsuit, but is still waiting to recover the costs for his proton therapy. An article in ProPublica, explains his story.
Insurers Are Not Providing Patients Reasons for Denials
Federal law and regulations require insurance companies to provide patients with claim files and information on denial decisions. A story in ProPublica follow several people as they file appeals on denied claims and the problems they faced in getting claim files.
How Lawmakers Undermine Vaccine Efforts
A story by KFF Health News highlights state efforts to limit information and access to COVID-19 vaccines. New laws limit health department efforts about vaccines, and Florida has even issued a guidance against becoming vaccined.
Navitus to Offer Unbranded Stelara Biosimilar, Remove Stelara from Formulary
March 13th 2025Lumicera Health Services, Navitus’ specialty pharmacy, has made a deal with Teva to offer an unbranded biosimilar that they estimate will save $112,000 and $336,000 per patient per year. Navitus will remove Stelara from formulary on July 1, 2025.
Read More
FDA Approves Neffy 1 mg Nasal Spray for Pediatric Patients
March 6th 2025Neffy 1 mg is now approved by the FDA to treat pediatric patients who weigh 33 to 65 lbs. Neffy was first FDA-approved as a 2 mg dose in August 2024 for the emergency treatment of anaphylaxis in children and adults weighing at least 66 lbs.
Read More